相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
David M. O'Malley et al.
GYNECOLOGIC ONCOLOGY (2020)
Multi-Parametric Standardization of Fluorescence Imaging Systems Based on a Composite Phantom
Dimitris Gorpas et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2020)
Gonadotropin-Releasing Hormone Receptor-Targeted Near-Infrared Fluorescence Probe for Specific Recognition and Localization of Peritoneal Metastases of Ovarian Cancer
Qiyu Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
Shan-Shan Yin et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
Katrin Kleinmanns et al.
EBIOMEDICINE (2020)
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
Katrin Kleinmanns et al.
EBIOMEDICINE (2020)
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer
Kimberly Fung et al.
MOLECULAR PHARMACEUTICS (2020)
Setting Standards for Reporting and Quantification in Fluorescence-Guided Surgery
Charlotte Hoogstins et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma
Fumou Sun et al.
CANCER RESEARCH (2019)
Antibody-drug conjugates in gynecologic malignancies
Elizabeth K. Lee et al.
GYNECOLOGIC ONCOLOGY (2019)
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
Ruediger Klapdor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy
Yue Han et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model
Lorenzo Ceppi et al.
ACS NANO (2019)
IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer
Jiao Song et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
A phase II, multicenter, open-label trial of OTL38 injection for the intraoperative imaging of folate receptor-alpha positive ovarian cancer
Leslie M. Randall et al.
GYNECOLOGIC ONCOLOGY (2019)
Latest developments in molecular tracers for fluorescence image-guided cancer surgery
Sophie Hernot et al.
LANCET ONCOLOGY (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery
Yvonne H. W. Derks et al.
THERANOSTICS (2019)
9 Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery
Pieterjan Debie et al.
ANTIBODIES (2019)
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
Minati Satpathy et al.
THERANOSTICS (2019)
Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model
Pieterjan Debie et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
High expression of integrin alpha v beta 3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors
Scott K. Shaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
Shirin Eyvazi et al.
CURRENT CANCER DRUG TARGETS (2018)
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
Kathleen N. Moore et al.
FUTURE ONCOLOGY (2018)
Emerging Intraoperative Imaging Modalities to Improve Surgical Precision
Israt S. Alam et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications
Bishnu P. Joshi et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma
Deniz Arik et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
Vasileios D. Sioulas et al.
GYNECOLOGIC ONCOLOGY (2017)
Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging
Marlene C. H. Hekman et al.
MOLECULAR PHARMACEUTICS (2017)
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
Kiyoko Nakamura et al.
ONCOLOGY REPORTS (2017)
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
Xinyu Deng et al.
ONCOTARGET (2017)
Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective
Martina Montagnana et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Oncologic Procedures Amenable to Fluorescence-guided Surgery
Kiranya E. Tipirneni et al.
ANNALS OF SURGERY (2017)
Role of Fluorophore Charge on the In Vivo Optical Imaging Properties of Near-Infrared Cyanine Dye/Monoclonal Antibody Conjugates
Kazuhide Sato et al.
BIOCONJUGATE CHEMISTRY (2016)
Fluorescence Imaging After Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal Cancer A Pilot Study
Gabriel Liberale et al.
ANNALS OF SURGERY (2016)
EpCAM as multi-tumour target for near-infrared fluorescence guided surgery
P. B. A. A. van Driel et al.
BMC CANCER (2016)
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer
Charlotte E. S. Hoogstins et al.
CLINICAL CANCER RESEARCH (2016)
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
Ben Davidson
HUMAN PATHOLOGY (2016)
Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging
Alisha V. DSouza et al.
JOURNAL OF BIOMEDICAL OPTICS (2016)
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse
Ignace Vergote et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Quirijn R. J. G. Tummers et al.
ONCOTARGET (2016)
CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation
Yao-An Shen et al.
ONCOTARGET (2016)
Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization
Marta M. Kijanka et al.
EJNMMI RESEARCH (2016)
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models1
Jose F. Ponte et al.
NEOPLASIA (2016)
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications
Ignace B. Vergote et al.
CANCER AND METASTASIS REVIEWS (2015)
Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation
Zhenqiu Liu et al.
GYNECOLOGIC ONCOLOGY (2015)
CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
Daniela Burgos-Ojeda et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation
Lizhong Wang et al.
NATURE COMMUNICATIONS (2015)
The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer
Quirijn R. J. G. Tummers et al.
PLOS ONE (2015)
Designing a Wearable Navigation System for Image-Guided Cancer Resection Surgery
Pengfei Shao et al.
ANNALS OF BIOMEDICAL ENGINEERING (2014)
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Markus Riester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
CD24 and S100A4 Expression in Resectable Pancreatic Cancers With Earlier Disease Recurrence and Poor Survival
Sang Hyub Lee et al.
PANCREAS (2014)
Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia
Emmet McCormack et al.
BLOOD (2013)
Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
A. V. Salnikov et al.
BRITISH JOURNAL OF CANCER (2013)
Optical Image-Guided Cancer Surgery: Challenges and Limitations
Stijn Keereweer et al.
CLINICAL CANCER RESEARCH (2013)
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
Deborah K. Armstrong et al.
GYNECOLOGIC ONCOLOGY (2013)
Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an αvβ3-integrin targeted agent
N. J. Harlaar et al.
GYNECOLOGIC ONCOLOGY (2013)
Image-guided cancer surgery using near-infrared fluorescence
Alexander L. Vahrmeijer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Clinical significance of CD24 as a predictor of bladder cancer recurrence
Chunxiao Liu et al.
ONCOLOGY LETTERS (2013)
CD24 Is an Effector of HIF-1-Driven Primary Tumor Growth and Metastasis
Shibu Thomas et al.
CANCER RESEARCH (2012)
CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Erhong Meng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
Jianping Deng et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
Jonathan B. Overdevest et al.
CANCER RESEARCH (2011)
Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
Filippo Bellati et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group
K. Baumann et al.
GYNECOLOGIC ONCOLOGY (2011)
Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
Anton G. T. Terwisscha van Scheltinga et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam et al.
NATURE MEDICINE (2011)
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial
Markus M. Heiss et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sharmila Makhija et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation
Sylvain Gioux et al.
MOLECULAR IMAGING (2010)
CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma
Akihiko Sano et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Intraepithelial T Cells and Tumor Proliferation
Sarah F. Adams et al.
CANCER (2009)
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA
Eyal Sagiv et al.
CANCER RESEARCH (2008)
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study
Angeles Alvarez Secord et al.
GYNECOLOGIC ONCOLOGY (2008)
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kimberly R. Kalli et al.
GYNECOLOGIC ONCOLOGY (2008)
In vivo optical Imaging of acute myeloid leukemia by green fluorescent protein: Time-domain autofluorescence decoupling, fluorophore quantification, and localization
Emmet McCormack et al.
MOLECULAR IMAGING (2007)
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D. S. Chi et al.
GYNECOLOGIC ONCOLOGY (2006)
Clinical activity of Pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: Potential predictive relationship with tumor HER2 activation status
Michael S. Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CD24 is a new oncogene, early at the multistep process-of colorectal cancer carcinogenesis
Eyal Sagiv et al.
GASTROENTEROLOGY (2006)
Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival
W Weichert et al.
CLINICAL CANCER RESEARCH (2005)
Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors
YL Choi et al.
GYNECOLOGIC ONCOLOGY (2005)
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer
G Kristiansen et al.
PROSTATE (2004)
Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades
J Jacob et al.
PANCREATOLOGY (2004)
Expression profile and prognostic significance of CD24, p53 and p21 in non-Hodgkin-lymphomas
P Went et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2004)
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
G Kristiansen et al.
BRITISH JOURNAL OF CANCER (2003)
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group
MA Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
